Skip to main content

Cresset Asset Management, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1761013 Chicago, IL

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$20,423,538
+$3,658,710 QoQ
Shares Held
260,937
+0.6% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#83
of 666 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. HALO ranks #2 (18.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
260,937 $20,423,538

All Filings in HALO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,423,538 260,937
2026-03-31 $16,764,828 259,397
2025-12-31 $14,988,719 222,715
2025-09-30 $16,402,491 223,650
2025-06-30 $15,067,957 289,657
2025-03-31 $19,549,533 306,371
2024-12-31 $15,936,698 333,334
2024-09-30 $19,124,628 334,113
2024-06-30 $15,196,076 290,223
2024-03-31 $11,420,950 280,751
2023-12-31 $7,683,910 207,898
2023-09-30 $6,875,503 179,987
2023-06-30 $3,807,116 105,548